Treatment of bipolar disorder is usually
by means of medication. A combination of mood stabilizing agents
with antidepressants, antipsychotics, and anticonvulsants is used to
regulate manic and depressive episodes.
Mood stabilizing agents such as lithium, carbamazepine, and
valproate are prescribed to regulate the manic highs and lows of
bipolar disorder:
Lithium (Cibalith-S, Eskalith, Lithane, Lithobid, Lithonate,
Lithotabs) is one of the oldest and most frequently prescribed drugs
available for the treatment of bipolar mania and depression. Because
the drug takes four to ten days to reach a therapeutic level in the
bloodstream, it is sometimes prescribed in conjunction with
neuroleptics and/or benzodiazepines to provide more immediate relief
of a manic episode. Lithium has also been shown to be effective in
regulating bipolar depression, but is not recommended for mixed
mania. Lithium may not be an effective long-term treatment option
for rapid cyclers, who typically develop a tolerance for it, or may
not respond to it. Possible side effects of the drug include weight
gain, thirst, nausea, and hand tremors. Prolonged lithium use may
also cause hyperthyroidism (a disease of the thryoid that is marked
by heart palpitations, nervousness, the presence of goiter, sweating,
and a wide array of other symptoms.)
Carbamazepine (Tegretol, Atretol) is an anticonvulsant drug usually
prescribed in conjunction with other mood stabilizing agents. The
drug is often used to treat bipolar patients who have not responded
well to lithium therapy. Blurred vision and abnormal eye movement
are two possible side effects of carbamazepine therapy. As of early
1998, carbamazepine did not have an FDA-cleared indication for mania.
Valproate (divalproex sodium, or Depakote; valproic acid, or
Depakene) is one of the few drugs available that has been proven
effective in treating rapid cycling bipolar and mixed states
patients. Valproate is prescribed alone or in combination with
carbamazepine and/or lithium. Stomach cramps, indigestion, diarrhea,
hair loss, appetite loss, nausea, and unusual weight loss or gain
are some of the common side effects of valproate. Note: valproate is
also approved for the treatment of mania.
Because antidepressants may stimulate manic episodes in some bipolar
patients, their use is typically short-term. Selective serotonin
reuptake inhibitors (SSRIs) or, less often, monoamine oxidase
inhibitors (MAO inhibitors) are prescribed for episodes of bipolar
depression. Tricyclic antidepressants used to treat unipolar
depression may trigger rapid cycling in bipolar patients and are,
therefore, not a preferred treatment option for bipolar depression.
SSRIs, such as fluoxetine (Prozac), sertraline (Zoloft), and
paroxetine (Paxil), regulate depression by regulating levels of
serotonin, a neurotransmitter. Anxiety, diarrhea, drowsiness,
headache, sweating, nausea, sexual problems, and insomnia are all
possible side effects of SSRIs.
MAOIs such as tranylcypromine (Parnate) and phenelzine (Nardil)
block the action of monoamine oxidase (MAO), an enzyme in the
central nervous system. Patients taking MAOIs must cut foods high in
tyramine (found in aged cheeses and meats) out of their diet to
avoid hypotensive side effects.
Bupropion (Wellbutrin) is a heterocyclic antidepressant. The exact
neurochemical mechanism of the drug is not known, but it has been
effective in regulating bipolar depression in some patients. Side
effects of bupropion include agitation, anxiety, confusion, tremor,
dry mouth, fast or irregular heartbeat, headache, and insomnia.
ECT, or electroconvulsive therapy, has a high success rate for
treating both unipolar and bipolar depression, and mania. However,
because of the convenience of drug treatment and the stigma
sometimes attached to ECT therapy, ECT is usually employed after all
pharmaceutical treatment options have been explored. ECT is given
under anesthesia and patients are given a muscle relaxant medication
to prevent convulsions. The treatment consists of a series of
electrical pulses that move into the brain through electrodes on the
patient's head. Although the exact mechanisms behind the success of
ECT therapy are not known, it is believed that this electrical
current alters the electrochemical processes of the brain,
consequently relieving depression. Headaches, muscle soreness,
nausea, and confusion are possible side effects immediately
following an ECT procedure. Temporary memory loss has also been
reported in ECT patients. In bipolar patients, ECT is often used in
conjunction with drug therapy.
Adjunct treatments are used in conjunction with a long-term
pharmaceutical treatment plan:
Long-acting benzodiazepines such as clonazepam (Klonapin) and
alprazolam (Xanax) are used for rapid treatment of manic symptoms to
calm and sedate patients until mania or hypomania have waned and
mood stabilizing agents can take effect. Sedation is a common
effect, and clumsiness, lightheadedness, and slurred speech are
other possible side effects of benzodiazepines.
Neuroleptics such as chlorpromazine (Thorazine) and haloperidol
(Haldol) are also used to control mania while a mood stabilizer such
as lithium or valproate takes effect. Because neuroleptic side
effects can be severe (difficulty in speaking or swallowing,
paralysis of the eyes, loss of balance control, muscle spasms,
severe restlessness, stiffness of arms and legs, tremors in fingers
and hands, twisting movements of body, and weakness of arms and
legs), benzodiazepines are generally preferred over neuroleptics.
Psychotherapy and counseling. Because bipolar disorder is thought to
be biological in nature, therapy is recommended as a companion to,
but not a substitute for, pharmaceutical treatment of the disease.
Psychotherapy, such as cognitive-behavioral therapy, can be a useful
tool in helping patients and their families adjust to the disorder,
in encouraging compliance to a medication regimen, and in reducing
the risk of suicide. Also, educative counseling is recommended for
the patient and family.
Calcium channel blockers (nimodipine, or Nimotop), typically used to
treat angina and hypotension, have been found effective, in a few
small studies, for treating rapid cyclers. Calcium channel blockers
stop the excess calcium build up in cells that is thought to be a
cause of bipolar disorder. They are usually used in conjunction with
other drug therapies such as carbamazepine or lithium.
Clozapine (Clozaril) is an atypical antipsychotic medication used to
control manic episodes in patients who have not responded to typical
mood stabilizing agents. The drug has also been a useful
prophylactic, or preventative treatment, in some bipolar patients.
Common side effects of clozapine include tachycardia (rapid heart
rate), hypotension, constipation, and weight gain. Agranulocytosis,
a potentially serious but reversible condition in which the white
blood cells that typically fight infection in the body are
destroyed, is a possible side effect of clozapine. Patients treated
with the drug should undergo weekly blood tests to monitor white
blood cell counts.
Risperidone (Risperdal) is an atypical antipsychotic medication that
has been successful in controlling mania in several clinical trials
when low doses were administered. The side effects of risperidone
are mild compared to many other antipsychotics (constipation,
coughing, diarrhea, dry mouth, headache, heartburn, increased length
of sleep and dream activity, nausea, runny nose, sore throat,
fatigue, and weight gain).
Lamotrigine (Lamictal, or LTG), an anticonvulsant medication, was
found to alleviate manic symptoms in a 1997 trial of 75 bipolar
patients. The drug was used in conjunction with divalproex
(divalproate) and/or lithium. Possible side effects of lamotrigine
include skin rash, dizziness, drowsiness, headache, nausea and
vomiting.
rTMS, or repeated transcranial magnetic stimulation is a new and
still experimental treatment for the depressive phase of bipolar
disorder. In rTMS, a large magnet is placed on the patient's head
and magnetic fields of different frequency are generated to
stimulate the left front cortex of the brain. Unlike ECT, rTMS
requires no anesthesia and does not induce seizures.
Alternative treatment
General recommendations include maintaining a calm environment,
avoiding over stimulation, getting plenty of rest, regular exercise,
and proper diet. Chinese herbs may soften mood swings. Biofeedback
is effective in helping some patients control symptoms such as
irritability, poor self control, racing thoughts, and sleep
problems. A diet low in vanadium (a mineral found in meats and other
foods) and high in vitamin C may be helpful in reducing depression. |